EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling

Robert T Maughan iD, Erin Macdonald-Dunlop, Lubna Haroon-Rashid, Louise Sorensen, Natalie Chaddock, Shauna Masters, Andrew Porter, Marta Peverelli iD, Charis Pericleous, Andrew Hutchings, James Robinson, Taryn Youngstein und 4 weitere

Arthritis & Rheumatology · 2025

DOI: 10.1002/art.43110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Robert T Maughan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Imperial College London, London, United Kingdom. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Takayasu Arteritis, Immunity, Innate. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRF_, MRF, Vasculitis UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Takayasu arteritis (TAK) and giant cell arteritis (GCA), the most common forms of large‐vessel vasculitis (LVV), can result in serious morbidity. Understanding the molecular basis of LVV should aid in developing better biomarkers and treatments.

Methods

Plasma proteomic profiling of 184 proteins was performed in two cohorts. Cohort 1 included patients with established TAK (n = 96) and large‐vessel GCA (LV‐GCA) (n = 35) in addition to healthy control participants (HCs) (n = 35). Cohort 2 comprised patients presenting acutely with possible cranial GCA (C‐GCA) in whom the diagnosis was subsequently confirmed (C‐GCA, n = 150) or excluded (Not C‐GCA, n = 89). Proteomic findings were compared to published transcriptomic data from LVV‐affected arteries.

Results

In cohort 1, comparison to HCs revealed 52 differentially abundant proteins (DAPs) in TAK and 72 DAPs in LV‐GCA. Within‐case analyses identified 16 and 18 disease activity–associated proteins in TAK and LV‐GCA, respectively. In cohort 2, comparing C‐GCA versus not C‐GCA revealed 31 DAPs. Analysis within C‐GCA cases suggested the presence of distinct endotypes, with more pronounced proteomic changes in the biopsy‐proven subgroup. Cross‐comparison of TAK, LV‐GCA, and biopsy‐proven C‐GCA revealed highly similar plasma proteomic profiles, with 26 shared DAPs including interleukin 6 (IL‐6), monocyte/macrophage‐related proteins (CCL7, CSF1), tissue remodeling proteins (TIMP1, TNC), and novel associations (TNFSF14, IL‐7R). Plasma proteomic findings reflected LVV arterial phenotype; for 42% of DAPs, the corresponding gene was differentially expressed in tissue.

Conclusion

These findings suggest shared pathobiology across the LVV spectrum involving innate immunity, lymphocyte homeostasis, and tissue remodeling. Network‐based analyses highlighted immune‐stromal cross‐talk and identified novel therapeutic targets (eg, TNFSF14).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell ArteritisTakayasu ArteritisImmunity, InnateHumansProteomicsFemaleMaleMiddle AgedAgedCohort StudiesAdultBiomarkersTissue Inhibitor of Metalloproteinase-1Interleukin-6Case-Control Studies

Substanzen

BiomarkersTissue Inhibitor of Metalloproteinase-1Interleukin-6

Autor:innen und Institutionen

  • Imperial College London, London, United Kingdom.
  • University of Leeds, Leeds, United Kingdom.
  • University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • University of Oxford, Oxford, United Kingdom.
  • London School of Hygiene & Tropical Medicine, London, United Kingdom.

ORCID-Profile: Robert T Maughan, Marta Peverelli, Ann W Morgan, James E Peters

Förderung

  • MRF_
  • MRF
  • Vasculitis UK
  • NIHR Imperial Biomedical Research Centre
  • National Institute for Health and Care Research Senior Investigator
  • Health Technology Assessment Programme
  • NIHR Leeds Biomedical Research Centre
  • National Institute for Health and Care Research Leeds MedTech and Invitro Diagnostics Co-operative

Zitieren

APA

Maughan, R. T., Macdonald-Dunlop, E., Haroon-Rashid, L., Sorensen, L., Chaddock, N., Masters, S., Porter, A., Peverelli, M., Pericleous, C., Hutchings, A., Robinson, J., Youngstein, T., Luqmani, R. A., Mason, J. C., Morgan, A. W., & Peters, J. E. (2025). Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling. Arthritis & Rheumatology. https://doi.org/10.1002/art.43110

Vancouver

Maughan RT, Macdonald-Dunlop E, Haroon-Rashid L, Sorensen L, Chaddock N, Masters S, et al. Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling. Arthritis & Rheumatology. 2025. doi:10.1002/art.43110

BibTeX
@article{Maughan2025,
  author = {Maughan, Robert T and Macdonald-Dunlop, Erin and Haroon-Rashid, Lubna and Sorensen, Louise and Chaddock, Natalie and Masters, Shauna and Porter, Andrew and Peverelli, Marta and Pericleous, Charis and Hutchings, Andrew and Robinson, James and Youngstein, Taryn and Luqmani, Raashid A and Mason, Justin C and Morgan, Ann W and Peters, James E},
  title = {Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  doi = {10.1002/art.43110}
}
Kostenlos starten →